This inventor holds 2 USPTO granted patents. Top assignee: Columbia University. Active years: 2004-2007.
Company Filing History:
Years Active: 2004-2007
Title: The Innovations of Anne A. Gershon
Introduction
Anne A. Gershon is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of virology, particularly in relation to the Varicella zoster virus (VZV). With a total of 2 patents, her work has advanced the understanding and treatment of viral infections.
Latest Patents
Gershon's latest patents include innovative methods and compositions related to VZV. One patent provides genetically engineered cell lines, recombinant vectors, and vaccines. It also outlines methods for generating an in vitro system for VZV, as well as techniques for reactivating the virus. Additionally, it offers a method for screening agents that treat VZV infections. Another patent focuses on VZV ORF29p protein-related compositions and methods. This invention includes compositions comprising 29p protein, monoclonal antibodies that bind to this protein, and methods for delivering agents into eukaryotic cells. Furthermore, it provides pharmaceutical compositions containing 29p protein and methods for detecting nucleic acid molecules encoding this protein.
Career Highlights
Anne A. Gershon is affiliated with Columbia University, where she has conducted extensive research in her field. Her work has not only contributed to scientific knowledge but has also paved the way for potential therapeutic applications.
Collaborations
Gershon has collaborated with notable colleagues, including Saul J. Silverstein and Michael D. Gershon. These partnerships have enhanced her research and expanded the impact of her inventions.
Conclusion
Anne A. Gershon's contributions to virology and her innovative patents demonstrate her commitment to advancing medical science. Her work continues to influence the field and offers hope for improved treatments for viral infections.